Exhaled nitric oxide measurement in patients affected by nasal polyposis

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 2, 2012, Pages 351-356

  Galli, Jacopo ^a   Montuschi, Paolo ^a   Passàli, Giulio Cesare ^a   Laruffa, Marianna ^a   Parrilla, Claudio ^a   Paludetti, Gaetano ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

asthma; nasal polyposis; nitric oxide

Indexed keywords

NITRIC OXIDE; STEROID;

ADULT; AGED; ARTICLE; ASTHMA; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPIRED AIR; FEMALE; HUMAN; ITALY; MALE; MEDICAL SOCIETY; NOSE POLYP; ONLINE ANALYSIS; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RHINOSINUSITIS; EXHALATION; METABOLISM; MIDDLE AGED;

ADULT; AGED; BREATH TESTS; EXHALATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; NITRIC OXIDE; PROSPECTIVE STUDIES;

EID: 84867367658     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812442322     Document Type: Article

References (38)

1. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci. 1990 ; 87: 682-685
2. Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy. 2006 ; 61: 717-724 (Pubitemid 43801406)
3. Watkins DN, Peroni DJ, Basclain KA, Garlepp MJ, Thompson PJ. Expression and activity of nitric oxide synthase in human airways epithelium. Am J Respir Cell Mol Biol. 1997 ; 16: 629-639 (Pubitemid 127498938)
4. Jeon SY, Kim E, Ma YW, Kim JP, Jung TG, Hwang EG. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways. Ann Otol Rhinol Laryngol. 2001 ; 110: 83-86 (Pubitemid 32096812)
5. Croen KD. Evidence for antiviral effect of nitric oxide. J Clin Invest. 1993 ; 91: 2446-2452
6. Sanders SP, Siekierski ES, Richards SM, Porter JD, Imani F, Proud D. Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J Allergy Clin Immunol. 2001 ; 107: 245-243
7. Mancinelli RL, McKay CP. Effects of nitric oxide and nitrogen dioxide on bacterial growth. Appl Environ Microbiol. 1983 ; 46: 198-202 (Pubitemid 13045860)
8. Al-Ali MK, Howarth PH. Nitric oxide and the respiratory system in health and disease. Respir Med. 1998 ; 92: 701-715 (Pubitemid 28279442)
9. Runer T, Cervin A, Lindberg S. Nitric oxide is a regulator of mucociliary activity in the upper respiratory tract. Otolaryngol Head Neck Surg. 1998 ; 119: 278-287 (Pubitemid 28425614)
10. Jain B, Rubinstain I, Robbins RA, Leise KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun. 1993 ; 191: 83-88 (Pubitemid 23222606)
11. Gaston B, Reilly J, Drazen JM, et al. Endogenous nitrogen oxides and broncodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA. 1993 ; 90: 10956-10961
12. Liu SF, Crawley DE, Barnes PJ, Evans TW. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis. 1991 ; 143: 32-37
13. Rubbo H, Radi R, Trujillo M, et al. Nitric oxide regulation of superoxide and oxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivates. J Biol Chem. 1994 ; 269: 26066-26075
14. Lindberg JON, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995 ; 1: 370-373
15. Bernareggi M, Cremona G. Measurement of exhaled nitric oxide in humans and animals. Pulm Pharmacol Ther. 1999 ; 12: 331-352 (Pubitemid 30015806)
16. Antonelli A, Bisetti A, Ferrara A, Grassi V Fisiologia e fisiopatologia del tratto respiratorio integrato. Antonelli A Bisetti A Ferrara A, ed. Brescia, Italy: Edizioni Scientifiche Valeas ; 1995 :
17. Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007 ; 62: 1-41 (Pubitemid 47556484)
18. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps group. Rhinol Suppl. 2007 ; 20: 1-136
19. Lamblin C, Saelens T, Bergoin C, Wallaert B. The common mucosal immune system in respiratory disease. Rev Mal Respir. 2000 ; 17: 941-946
20. Hens G, Vanaudenaerde BM, Bullens DM, et al. Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy. Allergy. 2008 ; 63: 261-267 (Pubitemid 351224671)
21. Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology. 1993 ; 31: 183-184 (Pubitemid 24049736)
22. National Asthma Education and Prevention Program: Expert Panel Report III. Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute;. 2007:1-61. NIH publication no. 08-5847. www.nhlbi.nih.gov
23. Official statement of the American Thoracic Society. Am J Respir Crit Care Med. 1999 ; 160: 2104-2117
24. Sanders SP, Siekierski ES, Richards SM, Porter JD, Imani F, Proud D. Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J Allergy Clin Immunol. 2001 ; 107: 245-243
25. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994 ; 269: 13725-13728 (Pubitemid 24191108)
26. Jeon SY, Kim E, Ma YW, Kim JP, Jung TG, Hwang EG. Nitric oxide mediates platelet activating factor-induced micorvascular leakage in rat airways. Ann Otol Rhinol Laryngol. 2001 ; 110: 83-86 (Pubitemid 32096812)
27. Tasman AJ, Bogatzki B, Heppt W, Hause-Kronberger C, Fisher A. Nitric oxide synthase in the innervation of the human nasal mucosa: correlation with neuropeptides and tyrosine hydroxylase. Laryngoscope. 1998 ; 108: 128-133 (Pubitemid 28053244)
28. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol (Stockh). 1997 ; 117: 113-117 (Pubitemid 27077016)
29. Arnal JF, Flores P, Ramis J, et al. Nasal nitric concentration in paranasal sinus inflammatory disease. Eur Resp J. 1999 ; 13: 307-312 (Pubitemid 29086825)
30. Watkins DN, Lewis RH, Basclain KA. Expression and localization of the inducible isoform of nitric oxide synthase in nasal epithelium. Clin Exp Allergy. 1998 ; 28: 211-219 (Pubitemid 28137337)
31. Kharitonov SA, Karalasingam R, O'Connor B, et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol. 1997 ; 99: 55-64
32. Passàli D, Damiani V, Passali FM, Passàli GC, Bellussi L. Pattern of expression of inducile nitric oxide synthase (iNOS) in rhinosinusal mucosa. Folia Otorhinolaryngologica. 2003 ; 8: 7-12
33. Zitt M. Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus report. Clin Ther. 2005 ; 27: 1238-1250 (Pubitemid 41393917)
34. Vijverberg SJH, Koenderman L, Koster ES, van der Ent CK, Raaijmakers JAM, Maitland-van der Zee AH. Biomarkers of therapy responsiveness in asthma: pitfalls and promises. Clin Exp Allergy. 2011 ; 41: 615-629
35. Williamson PA, Vaidyanathan S, Clearie K, Barnes M, Lipworth BJ. Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease?. Clin Exp Allergy. 2011 ; 10: 1-7
36. Yamamoto M, Tochino Y, Chibana K, et al. Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation. Clin Exp Allergy. 2011 ;:
37. Montuschi P, Santonico M, Mondino C, et al. Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest. 2010 ; 137: 790-796
38. Montuschi P, Mondino C, Koch P, Ciabattoni G, Barnes PJ, Baviera G. Effects of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in children with asthma. Chest. 2007 ; 132: 1876-1881